Equally contributing authors.
Pantothenate kinase-associated neurodegeneration is not a synucleinopathy
Version of Record online: 25 JAN 2013
© 2012 The Authors. Neuropathology and Applied Neurobiology © 2012 British Neuropathological Society
Neuropathology and Applied Neurobiology
Volume 39, Issue 2, pages 121–131, February 2013
How to Cite
Li, A., Paudel, R., Johnson, R., Courtney, R., Lees, A. J., Holton, J. L., Hardy, J., Revesz, T. and Houlden, H. (2013), Pantothenate kinase-associated neurodegeneration is not a synucleinopathy. Neuropathology and Applied Neurobiology, 39: 121–131. doi: 10.1111/j.1365-2990.2012.01269.x
- Issue online: 25 JAN 2013
- Version of Record online: 25 JAN 2013
- Accepted manuscript online: 15 MAR 2012 03:12AM EST
- Received 15 October 2011; Accepted after revision 7 March 2012; Published online Article Accepted on 14 March 2012
Table S1. Oligonucleotide primers used to amplify the exonic regions and flanking introns of the phospholipase A2, group VI (PLA2G6), the pantothenate kinase 2 (PANK2) and the ferritin light chain (FTL) genes.
Table S2. Antibodies used for immunohistochemistry investigation.
|nan1269_sm_tableS1.doc||51K||Supporting info item|
|nan1269_sm_tableS2.doc||55K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.